Yasmin Zeinolabediny

Dr. Yasmin Zeinolabediny


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Nima HeidariNima Heidari
Nima Heidari
MSMark Slevin
Mark Slevin
YZYasmin Zeinolabediny
Yasmin Zeinolabediny
DMDavide Meloni
Davide Meloni
SOStefano Olgiati
Stefano Olgiati
LALeonard Azamfirei
Leonard Azamfirei
Hip osteoarthritis (OA) is a major contributor to reduced quality of life and concomitant disability associated with lost working life months. Intra-articular injection of various biological materials has shown promise in alleviating symptoms and potentially slowing down the degenerative process. Here, we compared the effects of treatment of a cohort of 147 patients suffering from grade 1–4 hip OA; with either micro-fragmented adipose tissue (MFAT), or a combination of MFAT with platelet-rich plasma (PRP). We found significant improvements in both the visual analogue score for pain (VAS) and Oxford hip score (OHS) that were similar for both treatments with over 60% having an improvement in the VAS score of 20 points or more. These results suggest a positive role for intra-articular injection of MFAT + PRP as a treatment for hip osteoarthritis which may be important particularly in low body mass index (BMI) patients where the difficulty in obtaining sufficient MFAT for treatment could be offset by using this combination of biologicals.